Senior Financial Analyst Strategic Business Group @ (June 2006 - January 2007)
Senior Financial Analyst Drug Development @ (January 2005 - June 2006)
Ra Session Education
University of Houston
DBA (Doctor of Business Administration (Expected 2028))
East Texas A&M University
MSF (Finance)
East Texas A&M University
MBA (Strategic Management & Finance)
University of North Carolina at Charlotte
BSBA (Finance)
Society of Kauffman Fellows
Class 19 (Fellow (Life Science))
Ra Session Skills
Biopharmaceuticals
Biotechnology
CTMS
Clinical Development
Clinical Trials
Commercialization
Competitive Analysis
Competitive Intelligence
Corporate Development
Cross-functional Team Leadership
Drug Development
Drug Discovery
Due Diligence
FDA
Finance
Financial Modeling
Global Marketing
Licensing
Life Sciences
Lifesciences
Managed Care
Medical Devices
Mergers
Mergers & Acquisitions
Oncology
Pharmaceutical Industry
Pricing
Regulatory Affairs
Regulatory Submissions
Strategic Planning
Strategy
Technology Transfer
Valuation
Ra Session Summary
Ra Session, based in Texas, United States, is currently a Co-Founder, CEO and President at Signify Bio. Ra Session brings experience from previous roles at Taysha Gene Therapies, UT Southwestern Medical Center and ReCode Therapeutics. Ra Session holds a DBA in Doctor of Business Administration (Expected 2028) @ University of Houston. With a robust skill set that includes Biopharmaceuticals, Biotechnology, CTMS, Clinical Development, Clinical Trials and more. Ra Session has 4 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Ra Session?
Find contact details for 700 million professionals.